Regulation of glomerular filtration in essential hypertension: Role of abnormal Na+ transport and atrial natriuretic peptide

Journal of Nephrology

Volumn 15, Issue 5, 2002, Pages 489-496

  Semplicini, Andrea ^a   Ceolotto, Giulio ^a   Sartori, Michelangelo ^a   Maresca, Andrea ^a   Baritono, Elisabetta ^a   De Toni, Renzo ^a   Paparella, Italia ^a   Calò, Lorenzo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Arterial hypertension; Atrial natriuretic peptide; Glomerular filtration rate; Sodium reabsorption; Sodium lithium exchange

Indexed keywords

4 AMINOHIPPURIC ACID; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INULIN; LITHIUM ION; PLACEBO; QUINAPRIL; RENIN; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN 3; SPIRAPRIL;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ANALYTICAL PARAMETERS; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG EFFECT; ERYTHROCYTE; ESSENTIAL HYPERTENSION; FEEDBACK SYSTEM; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; KIDNEY BLOOD FLOW; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; PATHOGENESIS; PLASMA RENIN ACTIVITY; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE BLIND PROCEDURE; SODIUM ABSORPTION; SODIUM TRANSPORT; SPHYGMOMANOMETER;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE DETERMINATION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NATRIURESIS; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RENAL PLASMA FLOW; RENIN-ANGIOTENSIN SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 0036760072     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Walker WG, Neaton JR, Cutler JA, Neuwirth R, Cohen JD, for the MRFIT Research Group. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: Racial and treatment effects. JAMA 1992; 268: 3085-91.
2. Freedman BI, Iskander SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kidney Dis 1995; 25: 207-21.
3. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerulosclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1978; 307: 652-60.
4. Miller PL, Rennke HG, Meyer TW. Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol 1991; 261: F459-65.
5. Tolins JP, Shultz P, Raij L. Mechanisms of hypertensive glomerular injury. Am J Cardiol 1988; 62: 54-8.
6. Cortes P, Riser B, Narins RG. Glomerular hypertension and progressive renal disease: The interplay of mesangial cell stretch, cytokine formation and extracellular matrix synthesis. Contrib Nephrol 1996; 118: 229-33.
7. Braun C, Lang C, Hocher B, Gretz N, Van Der Woude FJ, Rhomeiss P. Influence of the renal endothelin system on the autoregulation of renal blood flow in spontaneously hypertensive rats. Kidney Blood Press Rep 1997; 20: 6-10.
8. Egido J. Vasoactive hormones and renal sclerosis. Kidney Int 1996; 49: 578-97.
9. Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993; 3: 1531-40.
10. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-7.
11. Higashi Y, Oshima T, Ozono R. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension 1995; 25 (part 2): 898-902.
12. Campo C, Lahera V, Garcia-Robles R. Aging abolishes the renal response to L-arginine in essential hypertension. Kidney Int 1996; 49 (suppl 55): S126-8.
13. Kurokawa K. Tubuloglomerular feedbeck: Its physiological and pathophysiological significance. Kidney Int 1998; 54 (suppl 67): S71-4.
14. Kimura G, Frem GJ, Brenner BM. Renal mechanisms of salt sensitivity in hypertension. Curr Opin Nephrol Hypertens 1994; 3: 1-12.
15. Shoback DM, Williams GH, Moore TM, Dluhy RG, Podolsky S, Hollemberg NK. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 1983; 72: 2115-24.
16. Redgrave JE, Rabinowe SL, Hollember NK, Williams GH. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. J Clin Invest 1985; 75: 1285-90.
17. Hollemberg NK, Williams GH. Abnormal renal function, sodium-volume homeostasis and renin system behaviour in normal-renin essential hypertension: The evolution of the non modulator concept. In Laragh JH, Brenner BM, Eds. Hypertension: Pathophysiology, Diagnosis and Management (2nd edn). New York: Raven Press 1995; 1837-56.
18. Williams RR, Hasstedt SJ, Hunt SC, Wu LL, Hopkins PN, Berry TD. Genetic traits related to hypertension and electrolyte metabolism. Hypertension 1991; 17 (supp I): I-69-I-73.
19. Weder AB. Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med 1986; 314: 198-201.
20. + exchanger isoforms in human proximal tubules. Kidney Int 2000; 58: 229-35.
21. Nosadini R, Semplicini A, Fioretto P, Lusiani L, Trevisan R, Donadon V. Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension. Hypertension 1991; 18: 191-8.
22. Carr S, Mbanya JC, Thomas T, Keavey P, Taylor R, Alberti KG, Wilkinson R. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport. N Engl J Med 1990; 322: 500-5.
23. Fine LG, Badie-Dezfooly B, Lowe AG, Hamzeh A, Salehmoghaddam S. Stimulation of Na/H antiporter is an early event in hypertrophy of renal proximal tubular cells. Proc Natl Acad Sci USA 1985; 82: 1736-40.
24. Redgrave J, Canessa M, Gleason R, Hollemberg NK, Williams GH. Red blood cell lithium-sodium countertransport in non-modulating essential hypertension. Hypertension 1989; 13: 721-6.
25. Canessa M, Adragna W, Solomon HS, Connolly T, Tosteson DC. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980; 302: 772-6.
26. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti G. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988; 318: 146-50.
27. Monciotti CG, Semplicini A, Morocutti A, Maioli M, Cipollina MR, Barzon I. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM. Diabetologia 1997; 40: 654-61.
28. + exchange in hypertensive patients. J Hypertens 1995; 13: 1566-70.
29. + handling in type I insulin-dependent diabetics during saline and ketone body infusion. Diabetes Res 1989; 11: 67-72.
30. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight are known. Arch Intern Med 1916; 17: 863-6.
31. Frohlich ED. Local hemodynamic changes in hypertension. Insight for therapeutic preservation of target organs. Hypertension 2001; 38: 1388-94.
32. + countertransport in hypertension. In Coca A, Garay RP, Eds. Ionic Transport in Hypertension. Boca Raton FLA USA, CRC Press 1994; 89-117.
33. Boerwinkle E, Turner ST, Weinshilboum R, Johnson M, Richelson E, Sing CF. Analysis of the distribution of erythrocyte sodium-lithium countertransport in a sample representative of the general population. Genet Epidemiol 1986; 3: 365-8.
34. Hasstedt SJ, Wu LL, Ash KO, Kuida H, Williams RR. Hypertension and sodium-lithium countertransport in Utah pedigrees: Evidence for major locus inheritance. Am J Hum Gen 1988; 43: 14-22.
35. Dadone MM, Hasstedt SJ, Hunt SC, Smith JB, Ash KO, Williams RR. Genetic analysis of sodium-lithium countertransport in 10 hypertension-prone kindreds. Am J Med Genet 1984; 17: 565-77.
36. Brugnara C, Corrocher R, Foroni L, Steinmayr M, Bonfanti F, DeSandre G. Lithium-sodium countertransport in erythrocytes of normal and hypertensive subjects: Relationship with age and plasma renin activity. Hypertension 1983; 5: 529-34.
37. Doria A, Fioretto P, Avogaro A, Carraro A, Morocutti A, Trevisan R. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 1991; 261: E684-91.
38. Strazzullo P, Cappuccio FP, Trevisan M, Siani A, Barba G, Ragone E. The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged male workers. J Hypertens 1993; 11: 815-22.
39. Zerbini G, Ceolotto G, Gaboury C, Mos L, Pessina AC, Canessa M. Semplicini A. Sodium-lithium countertransport has low affinity for sodium in hyperinsulinemic hypertensive subjects. Hypertension 1995; 25: 986-93.
40. Wooley RJ, Hentschel WM, Cormier C, Nutting S, Pead G, Zelenkov K. Increased sodium-lithium countertransport in erythrocytes of pregnant women. N Engl J Med 1982; 307: 412-6.
41. Corrocher R, Steimayr M, Ruzzenente O, Brugnara C, Bertinato L, Mazzi M. Elevation of red cell sodium-lithium countertransport in hyperlipidemias. Life Sci 1985; 36: 649-55.
42. Brent GA, Canessa M, Dluhy RG. Reversible alteration of red cell lithium-sodium countertransport in patients with thyroid disease. J Clin Endocrinol Metab 1989; 68: 1-7.
43. + exchanger in essential hypertension. J Cardiovasc Pharmacol 1988; 12: 92-8.
44. Aronson PS, Mahnensmith RL. The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res 1985; 57: 773-88.
45. Siffert W, During R. Sodium-proton exchange and primary hypertension: An update. Hypertension 1995; 26: 649-55.
46. + exchanger isoform-1 of immortalized lynphoblasts in diabetic nephropathy. Diabetes 1995; 44: 1180-5.
47. + exchange. Am J Physiol 1997; 272: C818-26.
48. + exchange activity by insulin and EGF. Am J Physiol 1994; 267: G364-G70.
49. Harris PJ, Hiranyachattada S, Antoine AM, Walker L, Reilly AM. Regulation of renal tubular sodium transport by angiotensin II and atrial natriuretic factor. Clin Exp Pharmacol Physiol 1996; 3 (suppl 3): S112-8.
50. Quan A, Baum M. Regulation of proximal tubule transport by endogenously produced angiotensin II. Nephron 2000; 84: 103-10.
51. Opocher G, Mantero F, Rocco S, Trevisan R, Fioretto P, Semplicini A. Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics. J Hypertens 1989; 7 (suppl): S236-7.
52. Brunner-La Rocca HP, Weilenmann D, Kiowski W, Maly FE, Candinas R, Follath F. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure. Am Heart J 1999; 138: 654-62.
53. Elijovich F, Laffer CL, Schiffrin EL. The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients. J Hum Hypertens 1997; 11: 313-39.
54. Fioretto P, Muollo B, Ben GP, Mollo F, Frigato F, Opocher G. Resistance to actions of atrial natriuretic factor in insulin-dependent diabetic hypertensives and improvement with angiotensin converting enzyme inhibitor treatment. J Hypertens 1991; 9 (suppl): S262-3.
55. Diez J, Alonso A, Garciandia A. Association of increased erytrocyte Na/H exchanger with renal Na retention in patients with essential hypertension. Am J Hypertens 1995; 8: 124-32.
56. Trevisan R, Viberti G. Sodium-hydrogen antiporter: Its possible role in the genesis of diabetic nephropathy. Nephrol Dial Transplant 1997; 12: 643-5.
57. Semplicini A, Mozzato MG, Samà B, Nosadini R, Fioretto P, Trevisan R. Sodium-hydrogen and lithium-sodium exchange in red cells of normotensive and hypertensive patients with insulin-dependent diabetes mellitus. Am J Hypertens 1989; 2: 174-7.
58. Ferri C, Piccoli A, Laurenti O, Bellini C, De Mattia G, Santucci A. Atrial natriuretic factor in hypertensive and normotensive diabetic patients. Diabetes Care 1994; 17: 195-200.
59. Chan JC, Cheung CK, Cockram CS, Critchley AJ, Swaminatham R. Atrial natriuretic peptide and renin-angiotensin-aldosterone system in non insulin-dependent diabetes mellitus. J Hum Hypertens 1994; 8: 451-6.
60. Tuck MT, Corry D, Trujillo A. Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med 1990; 88: 210-6.
61. Kimura G, Uzu T, Nakamura S, Inenaga T, Fujii T. High sodium sensitivity and glomerular hypertension/hyperfiltration in primary aldosteronism. J Hypertens 1996; 14: 1463-8.
62. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982; 307: 652-9.
63. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983; 23: 647-55.
64. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162-9.